Epsilon M&A Deal Report - Laborizon
Transaction Multiples for the Valuation of Private Companies
Biogroup-LCD SCM / Laborizon
No EMAT :
101055
Announced Date :
18/03/2020
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Biogroup-LCD SCM
Target :
Laborizon
Country :
Hauts-De-Seine
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Established in 2016 through the merger of six laboratories, Laborizon is a private laboratory network. > Comprises the following laboratories: ABO+ (Tours); Labomaine (Le Mans); Biorylis (La...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
|
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 20/12/2019 | Vivalto Santé | Mathilde Médical Développement (MMD) | France | * | 101025 |
| 18/06/2020 | Le Noble Age (LNA Santé) | Clinique Développement | Seine-Maritime | * | 100887 |
Source: Epsilon Research / EMAT
